The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria-Reference-Cited by-同舟云学术

The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria

Published:2021-08-19 Issue:11 Volume:20 Page:2166-2176
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Schultz Christopher W.^ORCID,McCarthy Grace A.,Nerwal Teena,Nevler Avinoam^ORCID,DuHadaway James B.^ORCID,McCoy Matthew D.^ORCID,Jiang Wei,Brown Samantha Z.^ORCID,Goetz Austin,Jain Aditi,Calvert Valerie S.,Vishwakarma Vikalp^ORCID,Wang Dezhen,Preet Ranjan,Cassel Joel,Summer Ross,Shaghaghi Hoora,Pommier Yves,Baechler Simone A.,Pishvaian Michael J.^ORCID,Golan Talia,Yeo Charles J.,Petricoin Emanuel F.,Prendergast George C.^ORCID,Salvino Joseph^ORCID,Singh Pankaj K.,Dixon Dan A.^ORCID,Brody Jonathan R.

Funder

NCI–CCR Intramural support

NIHNIGMSNIGMS

NCINIHNIH

OHSU Knight Cancer Institute

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Copper phosphate-rotenone nanocomposites for tumor therapy through autophagy blockage-enhanced triphosadenine supply interruption and lipid peroxidation accumulation;Chemical Engineering Journal;2024-09

2. Novel selective inhibitors of macropinocytosis-dependent growth in pancreatic ductal carcinoma;Biomedicine & Pharmacotherapy;2024-08

3. RNA-binding protein HuR reprograms immune T cells and promotes oral squamous cell carcinoma;Oral Oncology Reports;2024-06

4. Repurposing mitochondrial-targeting anthelmintic agents with GLUT1 inhibitor BAY-876 for cancer therapy;2024-05-05

5. In Vitro and Ex Vivo Synergistic Effect of Pyrvinium Pamoate Combined with Miltefosine and Paromomycin against Leishmania;Tropical Medicine and Infectious Disease;2024-01-25